Better nuclear MR through chemistry

University of Texas researchers have come up with a new chemical sensor that may facilitate more cost-effective use of nuclear magnetic resonance (NMR) spectroscopy in both clinical and research settings.

The material, called PCM-22, has ultraviolet properties and can quickly determine the purity of the heavy water that’s needed to operate NMR equipment.

“When you buy heavy water from a manufacturer it starts out ultrapure,” the lead researcher explains in a UT-Austin news item. “But as soon as you unscrew the bottle, hydrogen atoms from the air start swapping with deuterium atoms. A week later, all of the H’s have become scrambled with the D’s and it effectively ruins the heavy water. It’s an exchange that you can’t stop.”

PCM-22 can help, as it’s “sensitive enough to detect concentrations of ordinary water as low as 10 parts per million in a solution of heavy water, which could make it cheaper and faster to verify the purity of this important reagent.”

NMR spectroscopy is primarily used to evaluate metabolic changes in diseases affecting the brain.

The new material has promising environmental applications as well, including cleanups of chemical spills and safety assessments of old industrial sites.

Get the rest: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.